Skip to main content

Table 1 Main characteristics of the population

From: Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in an intensive care unit with no single rooms

Variable

All patients

n = 470

No ESBL colonization

n = 408

ESBL colonization

n = 62

p

Age (years)

66.0 [54.0, 77.0]

66 [54, 77]

68 [57, 78]

0.5

Age > 65 years

256 (54.5)

218 (53.4)

38 (61.3)

0.3

Male gender

283 (60.2)

245 (60.0)

38 (61.3)

0.9

SAPS II

46.0 [32.0, 62.0]

45 [32, 62]

49 [37.3, 55.5]

0.5

SOFA score

7.0 [4.0, 9.0]

6 [4, 9]

7 [4.5, 8.5]

0.6

Preexisting conditions

 Heart failure

65 (13.9)

53 (13.0)

12 (19.3)

0.2

 Peripheral arterial disease

60 (12.8)

45 (11.0)

15 (24.2)

0.007

 Diabetes

110 (23.5)

91 (22.3)

19 (36.8)

0.2

 Cirrhosis

21 (4.5)

18 (4.4)

3 (4.8)

0.8

 Chronic obstructive pulmonary disease

69 (14.7)

59 (14.4)

10 (16.1)

0.9

 Chronic kidney disease

61 (13.0)

52 (12.7)

9 (14.5)

0.8

 Immunosuppression

75 (16.0)

62 (15.2)

12 (19.3)

0.5

Mechanical ventilation

283 (60.2)

248 (60.8)

35 (56.5)

0.6

Catecholamine use

224 (47.8)

190 (46.6)

34 (54.8)

0.3

Duration of mechanical ventilation (days)

2.0 [0.0, 5.0]

2.0 [0.0, 5.0]

1.0 [0.0, 4.0]

0.4

ICU length of stay (days)

4.0 [2.0, 8.0]

4 [2.0, 8.0]

4.0 [3.0, 8.0]

0.8

Transfer from another unit

239 (50.9)

206 (50.5)

33 (53.2)

0.8

Postoperative care

109 (23.2)

94 (23.0)

14 (22.6)

0.9

Hospitalization within the previous 3 months

243 (51.7)

204 (50)

39 (62.9)

0.08

Antibiotics within the previous 3 months

81 (17.2)

68 (16.7)

13 (20.1)

0.5

Antibiotics during ICU

346 (73.6)

303 (74.3)

43 (69.3)

0.5

Duration of antibiotic therapy

3.0 [0.0, 6.0]

3.0 [0.0, 6.0]

3.0 [0.0, 7.0]

0.8

Mortality

62 (13.2)

56 (13.7)

6 (9.7)

0.2

  1. Categorical data are expressed as n (%)
  2. Quantitative data are expressed as median [IQR]